When to contact your healthcare provider: Severe or persistent nausea and vomiting that prevents adequate oral intake Signs of dehydration (decreased urination, dizziness, dry mouth) Severe abdominal pain, especially if persistent or radiating to the back Symptoms of hypoglycemia if taking tirzepatide with insulin or sulfonylureas (shakiness, sweating, confusion, rapid heartbeat) Unusual injection site reactions (severe pain, swelling, redness) Intractable vomiting or inability to keep fluids down Any other concerning symptoms For future injections: Review proper injection technique with your healthcare provider or a diabetes educator before your next dose
Many people come in simply because they want to feel more like themselves again, not because something is wrong. Can I combine multiple therapies in one visit
Monitoring energy levels through the treatment transition period helps determine whether the medication improves, worsens, or has no effect on endometriosis-related fatigue
5.5 Type 1 diabetes mellitus In T1DM, ferroptosis significantly contributes to pancreatic -cell death and the autoimmune response
Iannotta, D., A, A., Kijas, A